GHK-Cu is a copper II-coordinated tripeptide composed of glycine, histidine, and lysine
P., Moatshe, G., & LaPrade, R
But when doctors do prescribe them for overlapping metabolic issues (such as insulin resistance or obesity), the most commonly recommended medications include: Semaglutide (Ozempic/Wegovy) Tirzepatide (Mounjaro/Zepbound) technically a GLP-1 + GIP dual agonist Liraglutide (Saxenda) The choice depends on: How severe metabolic symptoms are Tolerance to side effects Cost and insurance status The clinicians expertise One study looking at GLP-1associated fat changes noted that visceral fat reduction can significantly improve inflammatory biomarkers, as shown in an adipose tissue study
They should not attempt to use the medication or assess its safety through visual inspection alone
Key Differences Between GLP-1 Medications and Traditional Methods When comparing GLP-1 medications vs
GLP-1 RAs are known to lower blood glucose by stimulating insulin production in the pancreatic -cells and inhibiting glucagon release by the pancreatic -cells, combined with slowing gastric emptying and reducing appetite and food consumption (29)